A Phase I Study of AT-101 With Cisplatin and Etoposide in Patients With Advanced Solid Tumors With an Expanded Cohort in Extensive-Stage Small Cell Lung Cancer

Investigational New Drugs - Netherlands
doi 10.1007/s10637-013-9999-7